These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 17823236)
1. Distribution of single-cell expanded marrow derived progenitors in a developing mouse model of osteogenesis imperfecta following systemic transplantation. Li F; Wang X; Niyibizi C Stem Cells; 2007 Dec; 25(12):3183-93. PubMed ID: 17823236 [TBL] [Abstract][Full Text] [Related]
2. Progenitors systemically transplanted into neonatal mice localize to areas of active bone formation in vivo: implications of cell therapy for skeletal diseases. Wang X; Li F; Niyibizi C Stem Cells; 2006 Aug; 24(8):1869-78. PubMed ID: 16675597 [TBL] [Abstract][Full Text] [Related]
3. Retrovirally transduced bone marrow stromal cells isolated from a mouse model of human osteogenesis imperfecta (oim) persist in bone and retain the ability to form cartilage and bone after extended passaging. Oyama M; Tatlock A; Fukuta S; Kavalkovich K; Nishimura K; Johnstone B; Robbins PD; Evans CH; Niyibizi C Gene Ther; 1999 Mar; 6(3):321-9. PubMed ID: 10435082 [TBL] [Abstract][Full Text] [Related]
4. Clinical-scale expansion of a mixed population of bone-marrow-derived stem and progenitor cells for potential use in bone-tissue regeneration. Dennis JE; Esterly K; Awadallah A; Parrish CR; Poynter GM; Goltry KL Stem Cells; 2007 Oct; 25(10):2575-82. PubMed ID: 17585167 [TBL] [Abstract][Full Text] [Related]
5. Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model. Kyriakou C; Rabin N; Pizzey A; Nathwani A; Yong K Haematologica; 2008 Oct; 93(10):1457-65. PubMed ID: 18728032 [TBL] [Abstract][Full Text] [Related]
6. Fates and osteogenic differentiation potential of human mesenchymal stem cells in immunocompromised mice. Xia Z; Locklin RM; Triffitt JT Eur J Cell Biol; 2008 Jun; 87(6):353-64. PubMed ID: 18417247 [TBL] [Abstract][Full Text] [Related]
7. Bone-directed expression of Col1a1 promoter-driven self-inactivating retroviral vector in bone marrow cells and transgenic mice. Stover ML; Wang CK; McKinstry MB; Kalajzic I; Gronowicz G; Clark SH; Rowe DW; Lichtler AC Mol Ther; 2001 Apr; 3(4):543-50. PubMed ID: 11319916 [TBL] [Abstract][Full Text] [Related]
8. Climbing exercise enhances osteoblast differentiation and inhibits adipogenic differentiation with high expression of PTH/PTHrP receptor in bone marrow cells. Menuki K; Mori T; Sakai A; Sakuma M; Okimoto N; Shimizu Y; Kunugita N; Nakamura T Bone; 2008 Sep; 43(3):613-20. PubMed ID: 18567552 [TBL] [Abstract][Full Text] [Related]
9. [Participation of transfused bone marrow cells in reparative osteohistogenesis]. Deev RV; Tsupkina NV; Serikov VB; Gololobov VG; Pinaev GP Tsitologiia; 2005; 47(9):755-9. PubMed ID: 16706204 [TBL] [Abstract][Full Text] [Related]
10. Differentiation and enrichment of hepatocyte-like cells from human embryonic stem cells in vitro and in vivo. Duan Y; Catana A; Meng Y; Yamamoto N; He S; Gupta S; Gambhir SS; Zern MA Stem Cells; 2007 Dec; 25(12):3058-68. PubMed ID: 17885076 [TBL] [Abstract][Full Text] [Related]
11. Gene targeting in stem cells from individuals with osteogenesis imperfecta. Chamberlain JR; Schwarze U; Wang PR; Hirata RK; Hankenson KD; Pace JM; Underwood RA; Song KM; Sussman M; Byers PH; Russell DW Science; 2004 Feb; 303(5661):1198-201. PubMed ID: 14976317 [TBL] [Abstract][Full Text] [Related]
12. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Horwitz EM; Prockop DJ; Fitzpatrick LA; Koo WW; Gordon PL; Neel M; Sussman M; Orchard P; Marx JC; Pyeritz RE; Brenner MK Nat Med; 1999 Mar; 5(3):309-13. PubMed ID: 10086387 [TBL] [Abstract][Full Text] [Related]
13. Experimental transplantation study for possible transformation of bone marrow cells in the mouse placenta. Kakui K; Itoh H; Sagawa N; Yura S; Takemura M; Kawamura M; Fujii S Placenta; 2005; 26(8-9):678-85. PubMed ID: 16085047 [TBL] [Abstract][Full Text] [Related]
14. Two distinct stem cell lineages in murine bone marrow. Koide Y; Morikawa S; Mabuchi Y; Muguruma Y; Hiratsu E; Hasegawa K; Kobayashi M; Ando K; Kinjo K; Okano H; Matsuzaki Y Stem Cells; 2007 May; 25(5):1213-21. PubMed ID: 17218403 [TBL] [Abstract][Full Text] [Related]
15. Intra-bone marrow cotransplantation of donor mesenchymal stem cells in pig-to-NOD/SCID mouse bone marrow transplantation facilitates short-term xenogeneic hematopoietic engraftment. Eguchi H; Kuroiwa Y; Matsui A; Sada M; Nagaya N; Kawano S Transplant Proc; 2008 Mar; 40(2):574-7. PubMed ID: 18374132 [TBL] [Abstract][Full Text] [Related]
16. Extracellular matrix scaffolds are repopulated by bone marrow-derived cells in a mouse model of achilles tendon reconstruction. Zantop T; Gilbert TW; Yoder MC; Badylak SF J Orthop Res; 2006 Jun; 24(6):1299-309. PubMed ID: 16649228 [TBL] [Abstract][Full Text] [Related]
17. Bone-marrow-derived cell differentiation into microglia: a study in a progressive mouse model of Parkinson's disease. Rodriguez M; Alvarez-Erviti L; Blesa FJ; RodrÃguez-Oroz MC; Arina A; Melero I; Ramos LI; Obeso JA Neurobiol Dis; 2007 Dec; 28(3):316-25. PubMed ID: 17897835 [TBL] [Abstract][Full Text] [Related]
18. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway. Otsuru S; Tamai K; Yamazaki T; Yoshikawa H; Kaneda Y Stem Cells; 2008 Jan; 26(1):223-34. PubMed ID: 17932420 [TBL] [Abstract][Full Text] [Related]
19. Cotransplantation of mouse embryonic stem cells and bone marrow stromal cells following spinal cord injury suppresses tumor development. Matsuda R; Yoshikawa M; Kimura H; Ouji Y; Nakase H; Nishimura F; Nonaka J; Toriumi H; Yamada S; Nishiofuku M; Moriya K; Ishizaka S; Nakamura M; Sakaki T Cell Transplant; 2009; 18(1):39-54. PubMed ID: 19476208 [TBL] [Abstract][Full Text] [Related]
20. Correction of a mineralization defect by overexpression of a wild-type cDNA for COL1A1 in marrow stromal cells (MSCs) from a patient with osteogenesis imperfecta: a strategy for rescuing mutations that produce dominant-negative protein defects. Pochampally RR; Horwitz EM; DiGirolamo CM; Stokes DS; Prockop DJ Gene Ther; 2005 Jul; 12(14):1119-25. PubMed ID: 15815702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]